Long-standing remission after 25-OH D3 treatment in a case of chronic myelomonocytic leukaemia

L. Mellibovsky, A. Diez, J. Aubia, X. Nogues, E. Perez-Vila, S. Serrano, Robert R. Recker

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

This report describes a case of chronic myelomonocytic leukaemia (CMML) in whom a complete remission was achieved and sustained 15 months after treatment with 25-OH vitamin D3. No side-effects were observed. Although vitamin D3 has been used in the treatment of myelodysplastic syndromes, to our knowledge this is the first case of longstanding remission in a patient with CMML. This 'differentiation therapy' might be considered as a possible alternative in the management of this disease.

Original languageEnglish
Pages (from-to)811-812
Number of pages2
JournalBritish Journal of Haematology
Volume85
Issue number4
StatePublished - 1993

Fingerprint

Leukemia, Myelomonocytic, Chronic
Cholecalciferol
Myelodysplastic Syndromes
Disease Management
Therapeutics

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Mellibovsky, L., Diez, A., Aubia, J., Nogues, X., Perez-Vila, E., Serrano, S., & Recker, R. R. (1993). Long-standing remission after 25-OH D3 treatment in a case of chronic myelomonocytic leukaemia. British Journal of Haematology, 85(4), 811-812.

Long-standing remission after 25-OH D3 treatment in a case of chronic myelomonocytic leukaemia. / Mellibovsky, L.; Diez, A.; Aubia, J.; Nogues, X.; Perez-Vila, E.; Serrano, S.; Recker, Robert R.

In: British Journal of Haematology, Vol. 85, No. 4, 1993, p. 811-812.

Research output: Contribution to journalArticle

Mellibovsky, L, Diez, A, Aubia, J, Nogues, X, Perez-Vila, E, Serrano, S & Recker, RR 1993, 'Long-standing remission after 25-OH D3 treatment in a case of chronic myelomonocytic leukaemia', British Journal of Haematology, vol. 85, no. 4, pp. 811-812.
Mellibovsky L, Diez A, Aubia J, Nogues X, Perez-Vila E, Serrano S et al. Long-standing remission after 25-OH D3 treatment in a case of chronic myelomonocytic leukaemia. British Journal of Haematology. 1993;85(4):811-812.
Mellibovsky, L. ; Diez, A. ; Aubia, J. ; Nogues, X. ; Perez-Vila, E. ; Serrano, S. ; Recker, Robert R. / Long-standing remission after 25-OH D3 treatment in a case of chronic myelomonocytic leukaemia. In: British Journal of Haematology. 1993 ; Vol. 85, No. 4. pp. 811-812.
@article{38ac071e75384a40ba3209597f97abf1,
title = "Long-standing remission after 25-OH D3 treatment in a case of chronic myelomonocytic leukaemia",
abstract = "This report describes a case of chronic myelomonocytic leukaemia (CMML) in whom a complete remission was achieved and sustained 15 months after treatment with 25-OH vitamin D3. No side-effects were observed. Although vitamin D3 has been used in the treatment of myelodysplastic syndromes, to our knowledge this is the first case of longstanding remission in a patient with CMML. This 'differentiation therapy' might be considered as a possible alternative in the management of this disease.",
author = "L. Mellibovsky and A. Diez and J. Aubia and X. Nogues and E. Perez-Vila and S. Serrano and Recker, {Robert R.}",
year = "1993",
language = "English",
volume = "85",
pages = "811--812",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Long-standing remission after 25-OH D3 treatment in a case of chronic myelomonocytic leukaemia

AU - Mellibovsky, L.

AU - Diez, A.

AU - Aubia, J.

AU - Nogues, X.

AU - Perez-Vila, E.

AU - Serrano, S.

AU - Recker, Robert R.

PY - 1993

Y1 - 1993

N2 - This report describes a case of chronic myelomonocytic leukaemia (CMML) in whom a complete remission was achieved and sustained 15 months after treatment with 25-OH vitamin D3. No side-effects were observed. Although vitamin D3 has been used in the treatment of myelodysplastic syndromes, to our knowledge this is the first case of longstanding remission in a patient with CMML. This 'differentiation therapy' might be considered as a possible alternative in the management of this disease.

AB - This report describes a case of chronic myelomonocytic leukaemia (CMML) in whom a complete remission was achieved and sustained 15 months after treatment with 25-OH vitamin D3. No side-effects were observed. Although vitamin D3 has been used in the treatment of myelodysplastic syndromes, to our knowledge this is the first case of longstanding remission in a patient with CMML. This 'differentiation therapy' might be considered as a possible alternative in the management of this disease.

UR - http://www.scopus.com/inward/record.url?scp=0027144521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027144521&partnerID=8YFLogxK

M3 - Article

C2 - 7918050

AN - SCOPUS:0027144521

VL - 85

SP - 811

EP - 812

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 4

ER -